In a nutshell This paper summarised the side effects associated with the use of nivolumab (Opdivo) for the treatment of Hodgkin Lymphoma. The main finding was that patients treated with nivolumab may experience immune-related side effects. Some background Brentuximab vedotin (Adcetris) and stem cell transplant are often used to treat classical...
Read MoreIn a nutshell This study aimed to investigate the effects of chemotherapy alone or chemotherapy plus anti-PD1 therapy in patients with relapsing/refractory (RR) Hodgkin's Lymphoma. The main finding was that anti-PD1 treatment enhances the effectiveness of chemotherapy in these patients. Some background Stem cell transplant (SCT) and...
Read More
In a nutshell This phase 2 trial aims to test the effectiveness of a combined treatment with nivolumab (Opdivo) and brentuximab vedotin (Adcetris) in older patients with Hodgkin lymphoma. The main outcome to be measured will be the response of the tumor to the treatment. This trial is recruiting in California, Columbia, Illinois, Minnesota, Missouri,...
Read More
In a nutshell The authors examined the safety and effectiveness of nivolumab (Opdivo) in patients with relapsed Hodgkin’s lymphoma after allogenic stem cell transplantation. The authors concluded that this treatment is generally safe and effective. Some background Hodgkin’s lymphoma (HL) is generally considered curable. However,...
Read More
